Illumina's divestiture of GRAIL boosts financials, while strong gross margins and DNA sequencing growth drive potential. See ...

Shares of genomics company Illumina (NASDAQ:ILMN) fell 4.2% in the morning session after a Citi analyst downgraded the stock ...

Novogene Europe announces the installation of its fifth Illumina NovaSeq X Plus sequencing system, expanding high-throughput ...

UofL Health – Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA approved assay for solid tumor testing. The test, known as ...

Shares of Illumina Inc. (NASDAQ:ILMN) dropped 3.8% on Wednesday after Citi downgraded the stock from Neutral to Sell, warning ...

Healthcare - MedLife, the largest private healthcare network in Romania, has announced the acquisition of the advanced ...

Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA ...

In the assessment of 12-month price targets, analysts unveil insights for Illumina, presenting an average target of $105.18, a high estimate of $185.00, and a low estimate of $77.00. Observing a ...

Illumina (NASDAQ:ILMN) shares slipped in the morning hours on Wednesday after Citi downgraded its stock to Sell from Neutral, arguing that the firm’s bearish views don’t support the recent rally in ...